成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

N-[6-chloro-5-[(1S)-2-methoxy-1-[(4S)-2-oxo-4-(trifluoromethyl)imidazolidin-1-yl]ethyl]pyridazin-3-yl]-2,2-dimethylpropanamide

N-[6-chloro-5-[(1S)-2-methoxy-1-[(4S)-2-oxo-4-(trifluoromethyl)imidazolidin-1-yl]ethyl]pyridazin-3-yl]-2,2-dimethylpropanamide Struktur
2915547-97-4
CAS-Nr.
2915547-97-4
Englisch Name:
N-[6-chloro-5-[(1S)-2-methoxy-1-[(4S)-2-oxo-4-(trifluoromethyl)imidazolidin-1-yl]ethyl]pyridazin-3-yl]-2,2-dimethylpropanamide
Synonyma:
N-[6-chloro-5-[(1S)-2-methoxy-1-[(4S)-2-oxo-4-(trifluoromethyl)imidazolidin-1-yl]ethyl]pyridazin-3-yl]-2,2-dimethylpropanamide
CBNumber:
CB413594958
Summenformel:
Molgewicht:
0
MOL-Datei:
Mol file

N-[6-chloro-5-[(1S)-2-methoxy-1-[(4S)-2-oxo-4-(trifluoromethyl)imidazolidin-1-yl]ethyl]pyridazin-3-yl]-2,2-dimethylpropanamide Eigenschaften

Sicherheit

N-[6-chloro-5-[(1S)-2-methoxy-1-[(4S)-2-oxo-4-(trifluoromethyl)imidazolidin-1-yl]ethyl]pyridazin-3-yl]-2,2-dimethylpropanamide Chemische Eigenschaften,Einsatz,Produktion Methoden

N-[6-chloro-5-[(1S)-2-methoxy-1-[(4S)-2-oxo-4-(trifluoromethyl)imidazolidin-1-yl]ethyl]pyridazin-3-yl]-2,2-dimethylpropanamide Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


N-[6-chloro-5-[(1S)-2-methoxy-1-[(4S)-2-oxo-4-(trifluoromethyl)imidazolidin-1-yl]ethyl]pyridazin-3-yl]-2,2-dimethylpropanamide Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Global( 4)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
ChengDu TongChuangYuan Pharmaceutical Co.Ltd 028-83379370 13880556291
tcy@tcypharm.com China 6274 58
Chemsigma International Co., Ltd. 025-58748998 18951874644
shijiao.wu@chemsigma.com China 1327 58
Shanghai Easy CDMO Co.,Ltd 021-61734564
August@easycdmo.com China 10030 58
Beijing Keyi Tongda Technology Development Co., Ltd 17743531240
kytd20@sina.com China 1514 58

  • N-[6-chloro-5-[(1S)-2-methoxy-1-[(4S)-2-oxo-4-(trifluoromethyl)imidazolidin-1-yl]ethyl]pyridazin-3-yl]-2,2-dimethylpropanamide
  • 2915547-97-4
Copyright 2019 ? ChemicalBook. All rights reserved